This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Humabs Biomed Sa, Vir Biotechnology, Inc.. Active years: 2025.
Company Filing History:
1 out of 38 
1 out of 8 Years Active: 2025
Title: Anna Bakardjiev: Innovator in HBV Therapy
Introduction
Anna Bakardjiev is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of medicine, particularly in the treatment of Hepatitis B virus (HBV) infections. Her innovative approach combines various therapies to enhance treatment efficacy.
Latest Patents
Anna holds a patent for her work titled "Combination HBV therapy." This patent outlines methods for treating HBV infection using combination therapies, which include an inhibitor of HBV gene expression or an agent that reduces HBV antigenic load, along with an anti-HBV antibody. This innovative therapy aims to improve patient outcomes in HBV treatment.
Career Highlights
Throughout her career, Anna has worked with notable companies such as Vir Biotechnology, Inc. and Humabs Biomed Sa. Her experience in these organizations has allowed her to develop and refine her innovative approaches to HBV therapy.
Collaborations
Anna has collaborated with esteemed colleagues, including Phillip S. Pang and Davide Corti. These partnerships have contributed to her success and the advancement of her research in the field.
Conclusion
Anna Bakardjiev is a trailblazer in the development of combination therapies for HBV treatment. Her innovative work and collaborations continue to impact the medical field positively.